Hicham Alaoui from Hopkinton, MA, age 23

Resumes

Vice President, Biology

view source

Location:

San Francisco, CA

Industry:

Biotechnology

Work:

Ardelyx, Inc.
Vice President, Biology
Symic Bio Dec 2017 - May 2018
Senior Vice President, Discovery Biology
Codexis, Inc. Dec 2017 - May 2018
Vice President, Biotherapeutics Research and Development
Genentech Oct 2014 - 2017
Director, Biochemical and Cellular Pharmacology
Genentech 2012 - 2014
Associate Director, Biochemical and Cellular Pharmacology

Education:

Mcgill University 1992 - 1999
Doctorates, Doctor of Philosophy, Microbiology, Immunology Sorbonne Université 1990 - 1991
Université Ibnou Zohr - Agadir
Bachelors, Biology

Skills:

Assay Development
Biochemistry
Biology
Biopharmaceuticals
Biotechnology
Cell
Cell Biology
Drug Discovery
Clinical Development
Immunoassays
Glp
Immunology
Pharmacology
Technology Transfer
Clinical Trials
Drug Development
Elisa
Fda
Infectious Diseases
Lifesciences
Hplc
In Vitro
Life Sciences
R&D
Qpcr
Cell Culture
In Vivo
Protein Purification
Protein Chemistry
Molecular Biology
Oncology
Pharmaceutical Industry
Validation
Western Blotting
Research and Development
Biomarker Discovery
High Throughput Screening
Cell Based Assays
Stem Cells
Inflammation
Cross Functional Team Leadership
Strategic Planning
Executive Leadership

Hicham Alaoui

view source

Hicham Cheikhi Alaoui

view source

Hicham Belghiti Alaoui

view source

Us Patents

Methods For Detecting Neutralizing Antibodies For Bone Morphogenetic Proteins
view source
US Patent:

20100209926, Aug 19, 2010
Filed:

Sep 26, 2008
Appl. No.:

12/679965
Inventors:

Hicham Alaoui - Hopkinton MA, US
Karen Lavery - Franklin MA, US
Assignee:

Stryker Corporation - Kalamazoo MI
International Classification:

C12Q 1/68
US Classification:

435 6
Abstract:

The present invention relates to methods of detecting neutralizing antibodies for bone morphogenetic proteins (BMP). More particularly, it relates to a highly specific, robust, rapid and accurate cell-based assay for detecting the presence of anti-BMP neutralizing antibodies.